A Brief Cannabis Use Psychoeducation Intervention for Eating Disorder Patients
- Sponsor
- St. Joseph's Healthcare Hamilton
- Study ID
- NCT07387965
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cannabis Use
- Eating Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 16 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Psychoeducation about risks of cannabis use — OTHERThis intervention will provide psychoeducation to eating disorder patients about the risks of using cannabis on mood, anxiety, sleep, substance use, gastrointestinal symptoms, eating disorder symptoms, and eating disorder treatment outcomes.
- Placebo control: Sleep hygiene psychoeducation — OTHEREating disorder patients in the control condition will receive psychoeducation about impacts of poor sleep on mental health and eating disorder treatment outcomes, and strategies to improve sleep hygiene.
Study Details
The goal of this clinical trial is to learn if providing eating disorder patients with education about the consequences of cannabis (marijuana) use on mental health, gastrointestinal symptoms, eating disorder symptoms, and eating disorder treatment effectiveness increases their knowledge about the cannabis use consequences, intention to reduce cannabis use, and motivation to seek treatment for their cannabis use. The main questions this study aims to answer are: 1. Does education about consequences of cannabis use increase eating disorder patients' knowledge about the risks of cannabis use? 2. Does education about the consequences of cannabis use increase intention to reduce cannabis use and seek cannabis use treatment among those with eating disorders? 3. Does cannabis use interfere with how successful eating disorder treatment is for eating disorder patients? All participants will receive 20 weeks of eating disorder treatment. In week 1 of treatment, participants will either be assigned to receive education about cannabis use consequences, or be assigned to a control condition where they receive education about consequences of poor sleep. Participants will be asked to complete a number of questionnaires that measure knowledge about cannabis use consequences, intention to reduce use and seek cannabis use treatment, eating disorder symptoms, and cannabis use habits. Researchers will assess how effective providing education about cannabis use consequences is on changing knowledge about cannabis use risks, intention to reduce use, and intention to seek cannabis use treatment. It will also be examined if effectiveness of eating disorder treatment is related to cannabis use habits.
Key Dates
- First listed
- Feb 4, 2026
- Start date
- Feb 4, 2026
- Status verified
- Jan 2026
- Primary completion
- Feb 4, 2028
- Completion
- Feb 4, 2028
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Cannabis psychoeducation interventionBrief psychoeducation will be provided to eating disorder patients seeking treatment regarding the impact of cannabis use on comorbid mental health conditions, sleep, gastrointestinal symptoms, eating disorder symptoms, and eating disorder treatment outcomes.
- Placebo Comparator: Psychoeducation control conditionBrief psychoeducation will be provided to eating disorder patients seeking treatment regarding the impact of poor sleep on mental health outcomes and appropriate sleep hygiene habits.
Primary Outcome Measure
Knowledge of cannabis use consequences [ Time Frame: Will be measured at baseline (i.e. 5 minutes into Session 1 of treatment for eating disorders before cannabis psychoeducation is administered), and again at 140 minutes into Session 1 of treatment for eating disorders. ]
Central Contacts
- Sarah McComb, Ph.D., C. Psych905-522-1155
- Keisha Gobin, Ph.D., C. Psych905.522.1155
Related Studies
- Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use DisordersPHASE2 · Recruiting · Medical University of South Carolina · Charleston, South Carolina
- Cannabis' Impact on Alcohol ConsumptionPHASE2 · Recruiting · Brown University · Providence, Rhode Island
- Behavioral Pharmacology of THC and Beta-MyrcenePHASE1 · Not Yet Recruiting · Johns Hopkins University · Baltimore, Maryland
- SV2A in Older AdultsPHASE1/PHASE2 · Recruiting · Yale University · New Haven, Connecticut